Throughout much of his career, Tin-Chuen Yeung has straddled two worlds within the life sciences: bench science and business development.
When Vivian Pinn was 4 years old, she announced that one day she would be a doctor.
At the National Institutes of Health, the premiere biomedical research institution in the United States, the struggle against human disease takes on particular significance when we consider the disproportionate impact these diseases have on the country's minority communities.
Creativity and innovation are essential to the pharmaceutical sector.
Early this year, Harvard University President Lawrence Summers made his now-famous remarks speculating that female scientists may have difficulty winning tenured faculty positions because of differences in "intrinsic aptitude."
Since the New York City life science technology-consulting firm Intrasphere Technologies opened an office in India, Samuel Goldman, cofounder and chief technology officer, says he works fairly bizarre hours, scheduling 6:00 A.M. meetings on a "regular basis."
As a young man at the height of the Vietnam War, Bogdan Dziurzynski had to make a choice.
D division from 850 to 1,100 scientists, recruiting, which used to be a fall ritual, has become a year-round affair, with teams of scientists and human resources hitting more than a dozen universities around the world hunting for talented prospects.
Roberto Rosenkranz decided to get an MBA after his PhD in pharmacology and toxicology out of pure interest in the field, not to advance his career.
For David Baker, landing a job in 1990 meant paging through newspaper help wanted sections, visiting the career center at University of California, Los Angeles to research biotech companies, sending lots of snail mail, and waiting weeks for an offer.